AAIPharma Services Corp. / Cambridge Major Laboratories, Inc. (AAI/CML) has expanded its IDBS E-WorkBook platform across analytical labs in the U.S. and will be incorporating its Netherlands facility in the coming months. All six of AAI/CML’s U.S. sites have been using E-WorkBook for three years, moving away from paper-based processes, in an effort to help streamline sample analysis and encourage collaboration.
 
E-WorkBook allows the company to record and share data from its API custom development, testing and manufacturing, analytical development and testing and drug product development, testing and manufacturing teams, on a single platform across the company’s seven sites. Lab analysts across the company use validated templates to standardize data input and reduce errors associated with transcribing paper-based results. 
 
“E-WorkBook is a critical part of our business operations, enabling us to harmonize documentation practices using electronic, automated and integrated templates, thereby increasing the speed with which we can test samples. We rely on the efficiency the platform delivers to turn around our analyses, and ultimately, deliver results to our clients faster,” said Ted Dolan, chief operating officer for AAI/CML. “Our previous paper-based approach required analysts to hand off test packages for quality review or ship packages between sites, causing unnecessary delays in review and final data write-up.”
  
Michael Hampton, vice president, North American Operations at IDBS said, “AAI/CML has been through a significant transformation, from a paper-based system to an electronic environment and it is certainly seeing the benefits. Giving lab analysts access across global sites ensures data can be shared quickly and efficiently, boosting collaboration opportunities and ensuring compliance in today’s tough regulatory arena.”